SynthesisFrontiers in immunology2026

Efficacy and safety of immune checkpoint inhibitors combined with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: a risk-stratified systematic review and meta-analysis.

Yingliang Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.